<p>CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, the upcoming Johnson & Johnson vaccine FDA advisory hearings, strategies for reopening K-12 schools, and other agency activities and priorities related to COVID-19 control. Recorded February 17, 2021.</p> <p>Related Article(s):</p> <ul> <li><a href= "https://edhub.ama-assn.org/jn-learning/video-player/10.1001/jama.2021.2338"> Coronavirus Update With CDC Director Rochelle Walensky - February 17, 2021</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2294"> SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities</a></li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2088"> SARS-CoV-2 Viral Variants—Tackling a Moving Target</a></li> </ul>

New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes

Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world's leading experts to explore the most pressing issues in health and health care.